116 related articles for article (PubMed ID: 35839400)
1. Long-Term Outcomes of Mesohepatectomy for Centrally Located Liver Tumors: Two-Decade Single-Center Experience.
Mehrabi A; Ramouz A; Golriz M; Khajeh E; Hackert T; Müller-Stich B; Strobel O; Hoffmann K; Büchler MW;
J Am Coll Surg; 2022 Aug; 235(2):257-266. PubMed ID: 35839400
[TBL] [Abstract][Full Text] [Related]
2. Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma.
Chen X; Li B; He W; Wei YG; Du ZG; Jiang L
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):264-70. PubMed ID: 24919609
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of a classification system for centrally located liver tumors in the setting of hepatocellular carcinoma after mesohepatectomy.
Qiu J; Chen S; Wu H; Du C
Surg Oncol; 2016 Dec; 25(4):441-447. PubMed ID: 26987943
[TBL] [Abstract][Full Text] [Related]
4. Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure.
Wu CC; Ho WL; Chen JT; Tang CS; Yeh DC; Liu TJ; P'eng FK
J Am Coll Surg; 1999 May; 188(5):508-15. PubMed ID: 10235579
[TBL] [Abstract][Full Text] [Related]
5. Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes.
Yang LY; Chang RM; Lau WY; Ou DP; Wu W; Zeng ZJ
Surgery; 2014 Nov; 156(5):1177-87. PubMed ID: 25444316
[TBL] [Abstract][Full Text] [Related]
6. Mesohepatectomy.
Scudamore CH; Buczkowski AK; Shayan H; Ho SG; Legiehn GM; Chung SW; Owen DA
Am J Surg; 2000 May; 179(5):356-60. PubMed ID: 10930479
[TBL] [Abstract][Full Text] [Related]
7. Mesohepatectomy as an option for the treatment of central liver tumors.
Mehrabi A; Mood ZA; Roshanaei N; Fonouni H; Müller SA; Schmied BM; Hinz U; Weitz J; Büchler MW; Schmidt J
J Am Coll Surg; 2008 Oct; 207(4):499-509. PubMed ID: 18926451
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive mesohepatectomy for centrally located liver lesions-a case series.
Birgin E; Hartwig V; Rasbach E; Seyfried S; Rahbari M; Reeg A; Jentschura SL; Téoule P; Reißfelder C; Rahbari NN
Surg Endosc; 2022 Dec; 36(12):8935-8942. PubMed ID: 35668311
[TBL] [Abstract][Full Text] [Related]
9. Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma.
Zuo CH; Qiu XX; Ouyang YZ; Zhang D; Xiao H; Mo SC; Tan CQ; Tang M; Zhu HZ
Mol Clin Oncol; 2014 Sep; 2(5):833-838. PubMed ID: 25054054
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic versus open mesohepatectomy for patients with centrally located hepatocellular carcinoma: a propensity score matched analysis.
Li W; Han J; Xie G; Xiao Y; Sun K; Yuan K; Wu H
Surg Endosc; 2019 Sep; 33(9):2916-2926. PubMed ID: 30498855
[TBL] [Abstract][Full Text] [Related]
11. Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients.
Chen XP; Qiu FZ; Lau WY; Zhang BX; Chen YF; Zhang WG; He SQ
Int J Colorectal Dis; 2008 May; 23(5):543-6. PubMed ID: 18193241
[TBL] [Abstract][Full Text] [Related]
12. Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
Cho HJ; Ahn YH; Sim MS; Eun JW; Kim SS; Kim BW; Huh J; Lee JH; Kim JK; Lee B; Cheong JY; Kim B
Gut Liver; 2022 Mar; 16(2):277-289. PubMed ID: 34810297
[TBL] [Abstract][Full Text] [Related]
13. [Exploration on laparoscopic hepatectomy on central liver tumor: a report of 40 cases].
Zhu SW; Yin XM; Yao LB; Liu Y; Liao CH; Wu YF; Li YF; Cai RY; Peng C
Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):517-522. PubMed ID: 31269614
[No Abstract] [Full Text] [Related]
14. Intrahepatic Glissonian access for mesohepatectomy in cirrhotic patients.
Dai WD; Hu JX; Miao XY; Zhong DW; Wen Y; Xiong SZ
Hepatogastroenterology; 2008; 55(85):1153-7. PubMed ID: 18795648
[TBL] [Abstract][Full Text] [Related]
15. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
[TBL] [Abstract][Full Text] [Related]
16. Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
Nakamura I; Iimuro Y; Hai S; Kondo Y; Hatano E; Fujimoto J
Eur Surg Res; 2018; 59(1-2):12-22. PubMed ID: 29332090
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the New ISGLS Definitions of Typical Posthepatectomy Complications.
Birgin E; Tesfazgi W; Knoth M; Wilhelm TJ; Post S; Rückert F
Scand J Surg; 2019 Jun; 108(2):130-136. PubMed ID: 30196769
[TBL] [Abstract][Full Text] [Related]
18. Anatomic mesohepatectomy versus extended hepatectomy for patients with centrally located hepatocellular carcinoma.
Li W; Li L; Minigalin D; Wu H
HPB (Oxford); 2018 Jun; 20(6):530-537. PubMed ID: 29366813
[TBL] [Abstract][Full Text] [Related]
19. The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients.
Lin XJ; Yang J; Chen XB; Zhang M; Xu MQ
J Surg Res; 2014 May; 188(2):489-95. PubMed ID: 24569034
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of indocyanine green (ICG)-R15 and Albumin-Indocyanine Green Evaluation (ALICE) grading system in the prediction of posthepatectomy liver failure and postoperative mortality in patients with hepatic alveolar echinococcosis.
Liang Y; Zhang Z; Dai Z; Cao R; Zhong D; Lai C; Yao Y; Feng T; Huang X
BMC Gastroenterol; 2022 Jun; 22(1):297. PubMed ID: 35701742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
